PEPS
/
REVIEW
Peptides
Guides
Research
Tools
Vendors
EN
EN
English
ES
Espanol
BR
Portugues
FR
Francais
KR
Korean
Sign Up
Peptides
Guides
Research
Tools
Vendors
Peptides
/
Research
/
Tesamorelin
/
Research
Research: Tesamorelin
FDA-approved GHRH analog for HIV-associated lipodystrophy
Tesamorelin
Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy
Drugs
2011
300
Review
Tesamorelin is the first and only approved treatment for reducing excess abdominal fat in HIV lipodystrophy, significantly reducing visceral adipose tissue over 26 weeks.
